Market Need Addresses a multi-billion dollar problem by providing long-lasting antimicrobial protection beyond traditional disinfectants, creating a strong value proposition for healthcare, food processing, and hospitality sectors seeking durable surface protection against pathogens.

Expanded Protocols Partnerships with universities and licensing from Cornell and Auburn indicate a robust R&D foundation and potential for accredited validation, easing adoption and enabling case-based selling to hospitals and processing facilities seeking proven antimicrobial solutions.

Evidence of Innovation Recent launch of AVA-003 and recognition as a technology leader position AvantGuard as a forward-looking partner, offering ongoing product opportunities and cross-sell potential to customers needing enhanced antiseptic compounds with sustained efficacy.

Financial Momentum Seed funding of 2.85 million and ongoing revenue generation up to several million dollars suggest growing market traction, enabling aggressive outreach to mid-market buyers in target industries and potential co-marketing or pilot programs.

Strategic Fit Industry focus on healthcare, food processing, and hospitality aligns with high-touch sales plays, enabling tailored messaging around surface protection, regulatory considerations, and long-term cost savings from reduced infections and illness-related downtime.